Search research articles
Contact Us
Filters
Showing results (101-110 of 458) with videos related to
Page
of 46
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2004
Hematologic toxicity of high-dose iodine-131-metaiodobenzylguanidine therapy for advanced neuroblastoma
Steven G DuBois, Julia Messina, John M Maris, et al.
Cancer Research
|
May 14, 2009
Comparison of primary neuroblastoma tumors and derivative early-passage cell lines using genome-wide single nucleotide polymorphism array analysis
Samuel L Volchenboum, Cheng Li, Shuli Li, et al.
Oncogene
|
July 20, 2007
Prevalence and functional consequence of PHOX2B mutations in neuroblastoma
E H Raabe, M Laudenslager, C Winter, et al.
Vaccine
|
June 2, 1998
Comparison of DNA application methods to reduce BRSV shedding in cattle
R S Schrijver, J P Langedijk, G M Keil, et al.
Oncogene
|
August 29, 2007
Deregulated Wnt/beta-catenin program in high-risk neuroblastomas without MYCN amplification
X Liu, P Mazanek, V Dam, et al.
Mabs
|
February 25, 2016
Differential killing of CD56-expressing cells by drug-conjugated human antibodies targeting membrane-distal and membrane-proximal non-overlapping epitopes
Yang Feng, Yanping Wang, Zhongyu Zhu, et al.
Molecular Pharmacology
|
September 27, 2006
The H+-linked monocarboxylate transporter (MCT1/SLC16A1): a potential therapeutic target for high-risk neuroblastoma
Jun Fang, Quintin J Quinones, Trevor L Holman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 3, 2019
PARP-1-Targeted Auger Emitters Display High-LET Cytotoxic Properties In Vitro but Show Limited Therapeutic Utility in Solid Tumor Models of Human Neuroblastoma
Hwan Lee, Aladdin Riad, Paul Martorano, et al.
Frontiers in Immunology
|
April 8, 2020
Immunogenicity and Immune Silence in Human Cancer
Mark Yarmarkovich, Alvin Farrel, Artemio Sison, et al.
Cancer Research
|
August 12, 1998
Identification of a consistent region of allelic loss on 1p32 in meningiomas: correlation with increased morbidity
E P Sulman, J P Dumanski, P S White, et al.
Page
of 46
Search research articles
Search
Showing results (101-110 of 458) with videos related to
Sort By:
Page
of 46
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2004
Hematologic toxicity of high-dose iodine-131-metaiodobenzylguanidine therapy for advanced neuroblastoma
Steven G DuBois, Julia Messina, John M Maris, et al.
Cancer Research
|
May 14, 2009
Comparison of primary neuroblastoma tumors and derivative early-passage cell lines using genome-wide single nucleotide polymorphism array analysis
Samuel L Volchenboum, Cheng Li, Shuli Li, et al.
Oncogene
|
July 20, 2007
Prevalence and functional consequence of PHOX2B mutations in neuroblastoma
E H Raabe, M Laudenslager, C Winter, et al.
Vaccine
|
June 2, 1998
Comparison of DNA application methods to reduce BRSV shedding in cattle
R S Schrijver, J P Langedijk, G M Keil, et al.
Oncogene
|
August 29, 2007
Deregulated Wnt/beta-catenin program in high-risk neuroblastomas without MYCN amplification
X Liu, P Mazanek, V Dam, et al.
Mabs
|
February 25, 2016
Differential killing of CD56-expressing cells by drug-conjugated human antibodies targeting membrane-distal and membrane-proximal non-overlapping epitopes
Yang Feng, Yanping Wang, Zhongyu Zhu, et al.
Molecular Pharmacology
|
September 27, 2006
The H+-linked monocarboxylate transporter (MCT1/SLC16A1): a potential therapeutic target for high-risk neuroblastoma
Jun Fang, Quintin J Quinones, Trevor L Holman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 3, 2019
PARP-1-Targeted Auger Emitters Display High-LET Cytotoxic Properties In Vitro but Show Limited Therapeutic Utility in Solid Tumor Models of Human Neuroblastoma
Hwan Lee, Aladdin Riad, Paul Martorano, et al.
Frontiers in Immunology
|
April 8, 2020
Immunogenicity and Immune Silence in Human Cancer
Mark Yarmarkovich, Alvin Farrel, Artemio Sison, et al.
Cancer Research
|
August 12, 1998
Identification of a consistent region of allelic loss on 1p32 in meningiomas: correlation with increased morbidity
E P Sulman, J P Dumanski, P S White, et al.
Page
of 46